Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-29

Clinical Trial Update: A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for capecitabine plus oxaliplatin (Xeloda + Oxaliplatin) in colorectal cancer has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)
  • Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-07-29